Survival Rate
"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
| Descriptor ID |
D015996
|
| MeSH Number(s) |
E05.318.308.985.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
| Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 12 | 12 | | 1997 | 0 | 25 | 25 | | 1998 | 0 | 16 | 16 | | 1999 | 0 | 17 | 17 | | 2000 | 0 | 19 | 19 | | 2001 | 0 | 19 | 19 | | 2002 | 0 | 22 | 22 | | 2003 | 0 | 19 | 19 | | 2004 | 0 | 21 | 21 | | 2005 | 0 | 32 | 32 | | 2006 | 0 | 41 | 41 | | 2007 | 0 | 37 | 37 | | 2008 | 0 | 48 | 48 | | 2009 | 0 | 40 | 40 | | 2010 | 1 | 51 | 52 | | 2011 | 1 | 63 | 64 | | 2012 | 1 | 49 | 50 | | 2013 | 0 | 82 | 82 | | 2014 | 2 | 104 | 106 | | 2015 | 0 | 83 | 83 | | 2016 | 2 | 85 | 87 | | 2017 | 2 | 105 | 107 | | 2018 | 1 | 92 | 93 | | 2019 | 0 | 105 | 105 | | 2020 | 0 | 79 | 79 | | 2021 | 0 | 52 | 52 | | 2022 | 0 | 8 | 8 | | 2023 | 0 | 8 | 8 | | 2024 | 0 | 60 | 60 | | 2025 | 0 | 61 | 61 | | 2026 | 0 | 37 | 37 |
To return to the timeline, click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
Zhang S, Singh O, Dazelle K, Quezado M, Cimino PJ, Abdullaev Z, Wu J, Lucas CH, Schreck KC, Holdhoff M, Pytel P, Goodwill V, Macaulay R, McDonald W, Seidman R, Wood M, Bharani K, Neltner J, Richard H, Chang K, Szymanski L, Yip S, Mukherjee A, Lopes Abath Neto O, Sharma SJ, Green R, Brown D, Gubbiotti MA, Ballester LY, Eschbacher J, Smith-Cohn M, Gokden M, Vincentelli C, Yong W, Lee J, Mount C, Fulmer J, Sun M, Ligon K, Santi M, Pai EL, Yeaney G, Alexandrescu S, Raghavan R, Fernandes I, Reis GF, Mandel J, Caccamo D, Rao S, Butt OH, Dahiya S, Stone S, Conway K, Nasrallah MP, Fuller C, Toland A, Lukas RV, Cachia D, Uhlmann EJ, McCord M, Helgager J, Han K, Perry A, Perez S, Daoud E, BeDell D, Highfield H, Kobalka P, Nix JS, Nduom E, Neill S, Gilbert MR, Lakis N, Fonseca A, Shen C, Yoda R, Monterroza L, Cohen AL, Cathcart S, Al Amin M, Campian J, Aldape K. High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort. Neuro Oncol. 2026 Oct 01; 28(10):2435-2448.
-
Abramson JS, Siddiqi T, Gordon LI, Lunning M, Wang M, Arnason J, Kamdar M, Maloney DG, Shadman M, Andreadis C, Sehgal A, Solomon SR, Ghosh N, Hidalgo-López JE, Wang J, Ding X, Ogasawara K, Singh A, Palomba ML. Five-year survival outcomes of lisocabtagene maraleucel in R/R LBCL from the TRANSCEND NHL 001 study. Blood. 2026 09 10; 148(11):1388-1393.
-
Biemond MJ, van Schaik J, Hamming JF, de Bruin JL, Brouwers JJWM, Dirven M, Gäbel G, van Herwaarden JA, Jongkind V, Matsumura JS, Mees BME, Schepers A, de Vries JPM, van der Vorst JR, Lindeman JHN. Sex- and Age-specific Outcomes After Ruptured Abdominal Aortic Aneurysm Repair: A Nationwide Cohort Study. Ann Surg. 2026 Nov 01; 284(5):943-949.
-
Sokol E, Naranjo A, Chen L, Mody R, DuBois SG, Bagatell R, Pinto N. Long-Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2026 Sep; 73(9):e70504.
-
Shibata Y, Ono Y, Kiritani S, Kobayashi K, Oba A, Ito H, Inoue Y, Takahashi Y. Clinical significance of bile duct margin carcinoma in situ in patients with distal cholangiocarcinoma undergoing pancreaticoduodenectomy. Surg Oncol. 2026 Oct; 68:102506.
-
Griesinger AM, Widener M, Donson AM, Mettetal A, Hankinson TC, Handler M, Mulcahy Levy JM, Lindsay HB, Macy ME, Foreman NK, Dorris K. Molecular biology and phase 1 study of GM-CSF and intrathecal trastuzumab in children with recurrent -posterior fossa ependymoma. Neuro Oncol. 2026 Jul 01; 28(7):1783-1793.
-
Chan PS, Bradley SM, Spertus JA, Fu Z, Jones P, Rolston DM, Girotra S. Resuscitation Quality Improvement Program for CPR Training and Cardiac Arrest Survival in Hospitals. JAMA Cardiol. 2026 Jul 01; 11(7):624-631.
-
Elad B, Raikhelkar JK, Clerkin KJ, Mehra MR, Goldstein DJ, Kanwar MK, Jorde UP, Cleveland JC, Shao J, Lee FS, O'Connell K, Takeda K, Sayer GT, Uriel N. Impact of Age on Long-Term Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial. JACC Heart Fail. 2026 Oct; 14(10):103183.
-
Kawashima J, Sahara K, Yuza K, Endo Y, Cauchy F, Aucejo F, Marques HP, Lopes R, Rodriguea A, Hugh T, Shen F, Maithel SK, Groot Koerkamp B, Popescu I, Kitago M, Weiss MJ, Martel G, Pulitano C, Aldrighetti L, Poultsides G, Ruzzente A, Bauer TW, Gleisner A, Homma Y, Endo I, Pawlik TM. Tumor Burden Modifies the Prognostic Impact of Adequate Lymph Node Dissection in Patients Undergoing Curative-Intent Resection for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2026 Sep; 33(9):7859-7869.
-
Carlo WF, Padilla LA, Kirklin JK, Cantor RS, Koehl D, Jacobs JP, Amdani S, Chatfield K, Desai M, Vaughn G, Montgomery CM, Boucek K, Gambetta K, Morales DLS. Comparing Outcomes of Heartmate 3 and Heart Transplantation in Older Children With Dilated Cardiomyopathy-Can Transplantation be Delayed or Avoided? Pediatr Transplant. 2026 Jun; 30(6):e70374.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|